Biphenyl

Biphenyl

SCHEMBL5087469

[LiH].[LiH].c1ccc(-c2ccccc2)cc1

nearest known ligand 0.90

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.90
MAPK1 P28482 2/20 0.56
TAAR1 Q96RJ0 2/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
HSD17B10 Q99714 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
NOTUM Q6P988 1/20 0.56
MMP3 P08254 1/20 0.56
BCL2L1 Q07817 1/20 0.56
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
ATM Q13315 1/20 0.50
SLC22A2 O15244 1/20 0.50
SLC22A1 O15245 1/20 0.50
SLC22A3 O75751 1/20 0.50
SLC6A4 P31645 1/20 0.50
MAOA P21397 1/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biphenyl SCHEMBL598676 1.00 ALDH1A1 (0.90) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL7411979 0.95 ALDH1A1 (0.82) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL7993413 0.95 ALDH1A1 (0.82) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL29008551 0.95 ALDH1A1 (1.00) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
SCHEMBL30629023 0.95 ALDH1A1 (1.00) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
SCHEMBL30108088 0.95 ALDH1A1 (1.00) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL2548048 0.95 ALDH1A1 (1.00) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL28890607 0.95 ALDH1A1 (1.00) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL164 0.95 ALDH1A1 (1.00) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL4002609 0.95 ALDH1A1 (1.00) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0316440-B1 System and method for providing localized Mössbauer absorption in an organic medium MILLS RANDELL L (US) 1996-01-03 EP claimed
WO-2024216499-A1 POSITIVE ELECTRODE ACTIVE MATERIAL COMPOSITION, POSITIVE ELECTRODE SHEET, BATTERY, AND ELECTRIC DEVICE 宁德时代新能源科技股份有限公司 2024-10-24 WO disclosed
CN-117777198-A Triarylphosphine compound based on phosphafluorene structure and preparation method thereof 北京大学 2024-03-29 CN disclosed
CN-117777199-A Acyl phosphine oxide compound based on phosphafluorene structure and preparation method thereof 北京大学 2024-03-29 CN disclosed
US-11820733-B2 Process for producing sulfonic acid group-containing monomer ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-11-21 US disclosed
CN-115477673-A Diphosphine compound based on phosphafluorene structural unit and preparation method thereof 北京大学 2022-12-16 CN disclosed
CN-115477675-A Phosphofluorene metal salt compound and preparation method thereof 北京大学 2022-12-16 CN disclosed
CN-115477574-A Synthesis of hexafluorobenzotetraphenyl and tetrafluorotetraphenyl discotic liquid crystal semiconductors 四川师范大学 2022-12-16 CN disclosed
CN-115477674-A Organophosphorus compounds based on phosphafluorene structural units and preparation method thereof 北京大学 2022-12-16 CN disclosed
CN-115477574-A Synthesis of hexafluorobenzotetraphenyl and tetrafluorotetraphenyl discotic liquid crystal semiconductors 四川师范大学 2022-12-16 CN disclosed
WO-2004076502-A1 SUPPORTED MULTINUCLEAR METALLOCENE CATALYST FOR OLEFIN POLYMERIZATION AND METHOD FOR PREPARING THE SAME HONAM PETROCHEMICAL CORPORATION (KR) 2004-09-10 WO disclosed
US-20040072677-A1 Multinuclear metallocene catalyst HONAM PETROCHEMICAL CORPORATION (KR) 2004-04-15 US disclosed
CN-1489601-A Multinuclear metallocene catalyst ������ѧ��ʽ���� 2004-04-14 CN disclosed
EP-1363955-A1 MULTINUCLEAR METALLOCENE CATALYST Honam Petrochemical Corporation (KR) 2003-11-26 EP disclosed
WO-2002060964-A1 MULTINUCLEAR METALLOCENE CATALYST HONAM PETROCHEMICAL CORPORATION (KR) 2002-08-08 WO disclosed
EP-0624152-B1 PROCESS FOR PREPARING KETONE ENANTIOMER PFIZER (US) 1996-11-13 EP disclosed
EP-0316440-B1 System and method for providing localized Mössbauer absorption in an organic medium MILLS RANDELL L (US) 1996-01-03 EP disclosed
EP-0624152-A1 PROCESS FOR PREPARING KETONE ENANTIOMER. PFIZER (US) 1994-11-17 EP disclosed
WO-1993012062-A1 PROCESS FOR PREPARING KETONE ENANTIOMER PFIZER INC. (US) 1993-06-24 WO disclosed
EP-0510873-A2 Self-reinforcing siloxane elastomers DOW CORNING CORPORATION (US) 1992-10-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11820733-B2 Process for producing sulfonic acid group-containing monomer FOS, CLCN2, CLIC1 ALDH1A1 972/4885MAPK1 1214/4885TAAR1 3740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.